Is BIO or MEDP cheaper?

On trailing earnings, MEDP is cheaper: BIO trades at a 47.77 P/E and MEDP at 28.71.

Which has grown faster, BIO or MEDP?

Over the past five years, MEDP grew revenue faster — BIO at a -0.84% CAGR versus MEDP at 22.91%.

Is BIO or MEDP more profitable?

MEDP runs the higher net margin — BIO at 6.52% versus MEDP at 17.19%.

Which has been the better investment, BIO or MEDP?

Over the past 5-year, MEDP delivered the higher annualized total return — BIO at 7.55% versus MEDP at 20.25%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Medpace Holdings, Inc. (MEDP)

MEDP leads on 11 of 15 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

$7.84B

$289.95Healthcare

MEDP

Medpace Holdings, Inc.

$13.05B

$457.09Healthcare

Total return — BIO vs MEDP

growth of $100 · last 10y

BIO +88.1%MEDP +1561.0%MEDP compounded faster

Log scale — wide-divergence pair

BIO MEDP

BIO vs MEDP: by the numbers

•MEDP is the larger company ($13.05B vs $7.84B market cap).
•MEDP trades at the lower earnings multiple (28.71 vs 47.77 P/E).
•MEDP converts more revenue to profit (17.19% vs 6.52% net margin).
•MEDP grew revenue faster over the past five years (22.91% vs -0.84% CAGR).

Which is better, BIO or MEDP?

Metric tally: BIO 4 · MEDP 11

It depends on what you're optimizing for:

ValueMEDP(lower P/E)

GrowthMEDP(faster 5Y revenue CAGR)

QualityMEDP(higher ROIC)

Metrics side by side

Valuation

Metric	BIO	MEDP
P/E ratio	47.77	28.71●
Forward P/E	29.10	24.88●
P/S ratio	3.02●	4.94
P/B ratio	1.14●	22.13
PEG ratio	—	1.82
EV / EBITDA	18.50●	21.18
FCF yield	4.57%	5.57%●

Profitability

Metric	BIO	MEDP
Gross margin	51.87%●	29.07%
Operating margin	9.25%	21.02%●
Net margin	6.52%	17.19%●
ROE	2.46%	76.95%●
ROIC	2.04%	67.94%●

Growth (annualized)

Metric	BIO	MEDP
Revenue CAGR (5Y)	-0.84%	22.91%●
EPS CAGR (5Y)	-26.27%	30.90%●
FCF CAGR (5Y)	-7.57%	25.76%●
Total return CAGR (5Y)	-13.89%	20.25%●

Frequently asked

Which is better, BIO or MEDP?: It depends on your goal. value: MEDP (lower P/E); growth: MEDP (faster 5Y revenue CAGR); quality: MEDP (higher ROIC). Across all compared metrics, MEDP leads 11 to 4.
Is BIO or MEDP cheaper?: On trailing earnings, MEDP is cheaper: BIO trades at a 47.77 P/E and MEDP at 28.71.
Which has grown faster, BIO or MEDP?: Over the past five years, MEDP grew revenue faster — BIO at a -0.84% CAGR versus MEDP at 22.91%.
Is BIO or MEDP more profitable?: MEDP runs the higher net margin — BIO at 6.52% versus MEDP at 17.19%.
Which has been the better investment, BIO or MEDP?: Over the past 5-year, MEDP delivered the higher annualized total return — BIO at 7.55% versus MEDP at 20.25%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Medpace P/E ratio Bio-Rad Laboratories dividend yield Medpace dividend yield Bio-Rad Laboratories ROE Medpace ROE Bio-Rad Laboratories operating margin Medpace operating margin Bio-Rad Laboratories revenue growth Medpace revenue growth Bio-Rad Laboratories free cash flow Medpace free cash flow

Bio-Rad Laboratories & Medpace appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.